Showing results (111-120 of 126) with videos related to
Sort By:
Pageof 13
European Journal of Nuclear Medicine and Molecular Imaging|October 10, 2021
Outcome after PSMA-PET/CT-based salvage radiotherapy for nodal recurrence after radical prostatectomyPaul Rogowski, Christian Trapp, Rieke von Bestenbostel, et al.Theranostics|June 8, 2022
APOBEC-mediated mutagenesis is a favorable predictor of prognosis and immunotherapy for bladder cancer patients: evidence from pan-cancer analysis and multiple databasesRun Shi, Xin Wang, Yang Wu, et al.European Journal of Nuclear Medicine and Molecular Imaging|March 23, 2023
Metabolic patterns on [18F]FDG PET/CT in patients with unresectable stage III NSCLC undergoing chemoradiotherapy ± durvalumab maintenance treatmentAdrien Holzgreve, Julian Taugner, Lukas Käsmann, et al.Frontiers in Oncology|October 18, 2021
A Multi-Institutional Analysis of Prostate Cancer Patients With or Without 68Ga-PSMA PET/CT Prior to Salvage Radiotherapy of the Prostatic FossaNina-Sophie Schmidt-Hegemann, Constantinos Zamboglou, Reinhard Thamm, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 14, 2018
Outcome after PSMA PET/CT based salvage radiotherapy in patients with biochemical recurrence after radical prostatectomy: a bi-institutional retrospective analysisNina-Sophie Schmidt-Hegemann, Christian Stief, Tak-Hyun Kim, et al.NPJ Digital Medicine|April 26, 2026
Integrating multimodal clinical data with a large model for prostate cancer diagnosisChengbang Wang, Yuan Tian, Shaojie Yin, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 30, 2025
PSMA PET-Positive Local Recurrences in the Prostate Bed Region and Their Coverage Based on Clinical Target Volume Delineation Guidelines from ESTRO-ACROP, PERYTON, FROGG, GFRU, and RTOGErik F Moar, Michael Keilholz, Gabriel T Sheikh, et al.Oncotarget|June 4, 2016
A novel HSP90 inhibitor with reduced hepatotoxicity synergizes with radiotherapy to induce apoptosis, abrogate clonogenic survival, and improve tumor control in models of colorectal cancerLinda Kinzel, Anne Ernst, Michael Orth, et al.Frontiers in Oncology|July 8, 2021
Patient-Reported and Oncological Outcomes of Salvage Therapies for PSMA-Positive Nodal Recurrent Prostate Cancer: Real-Life Experiences and Implications for Future Trial DesignAlexander Kretschmer, Johanna Milow, Chukwuka Eze, et al.Medical Physics|October 27, 2016
Investigating deformable image registration and scatter correction for CBCT-based dose calculation in adaptive IMPTChristopher Kurz, Florian Kamp, Yang-Kyun Park, et al.Pageof 13